These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17298224)

  • 1. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
    Frank J; Poblete-Gutiérrez P; Weiskirchen R; Gressner O; Merk HF; Lammert F
    Physiol Res; 2006; 55 Suppl 2():S75-83. PubMed ID: 17298224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
    Tannapfel A; Stölzel U; Köstler E; Melz S; Richter M; Keim V; Schuppan D; Wittekind C
    Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
    Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.
    Kratka K; Dostalikova-Cimburova M; Michalikova H; Stransky J; Vranova J; Horak J
    Br J Dermatol; 2008 Sep; 159(3):585-90. PubMed ID: 18565178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF; Armas RM; Frank J; Poblete PG
    Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in porphyria cutanea tarda.
    Sampietro M; Fiorelli G; Fargion S
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
    Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
    Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
    Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G
    Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
    Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
    Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.